222 related articles for article (PubMed ID: 23615507)
1. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α.
Matoba K; Kawanami D; Okada R; Tsukamoto M; Kinoshita J; Ito T; Ishizawa S; Kanazawa Y; Yokota T; Murai N; Matsufuji S; Takahashi-Fujigasaki J; Utsunomiya K
Kidney Int; 2013 Sep; 84(3):545-54. PubMed ID: 23615507
[TBL] [Abstract][Full Text] [Related]
2. Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy.
Matoba K; Kawanami D; Nagai Y; Takeda Y; Akamine T; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820432
[TBL] [Abstract][Full Text] [Related]
3. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
[TBL] [Abstract][Full Text] [Related]
4. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H
Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585
[TBL] [Abstract][Full Text] [Related]
6. HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.
Nayak BK; Shanmugasundaram K; Friedrichs WE; Cavaglierii RC; Patel M; Barnes J; Block K
Diabetes; 2016 May; 65(5):1387-97. PubMed ID: 26908870
[TBL] [Abstract][Full Text] [Related]
7. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
[TBL] [Abstract][Full Text] [Related]
8. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.
Komers R; Oyama TT; Beard DR; Tikellis C; Xu B; Lotspeich DF; Anderson S
Kidney Int; 2011 Feb; 79(4):432-42. PubMed ID: 20962741
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
11. Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1α expression and oxygen metabolism.
Takiyama Y; Harumi T; Watanabe J; Fujita Y; Honjo J; Shimizu N; Makino Y; Haneda M
Diabetes; 2011 Mar; 60(3):981-92. PubMed ID: 21282369
[TBL] [Abstract][Full Text] [Related]
12. ROCK2 regulates TGF-β-induced expression of CTGF and profibrotic genes via NF-κB and cytoskeleton dynamics in mesangial cells.
Nagai Y; Matoba K; Kawanami D; Takeda Y; Akamine T; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K; Nishimura R
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F839-F851. PubMed ID: 31364374
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
Packer M
Am J Kidney Dis; 2021 Feb; 77(2):280-286. PubMed ID: 32711072
[TBL] [Abstract][Full Text] [Related]
14. Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway.
Sun X; Huang K; Haiming X; Lin Z; Yang Y; Zhang M; Liu P; Huang H
Clin Sci (Lond); 2020 Jul; 134(13):1573-1592. PubMed ID: 32558900
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].
Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521
[TBL] [Abstract][Full Text] [Related]
16. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
[TBL] [Abstract][Full Text] [Related]
17. Effects of a Rho kinase inhibitor on the sequential expression of ICAM-1, HIF-1α, Bcl-2 and caspase-3 in the retina of rats with oxygen-induced retinopathy.
Wang H; Chen X
Int J Mol Med; 2013 Aug; 32(2):457-63. PubMed ID: 23739770
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy.
Bessho R; Takiyama Y; Takiyama T; Kitsunai H; Takeda Y; Sakagami H; Ota T
Sci Rep; 2019 Oct; 9(1):14754. PubMed ID: 31611596
[TBL] [Abstract][Full Text] [Related]
19. Rho-kinase inhibitor restores glomerular fatty acid metabolism in diabetic kidney disease.
Nagai Y; Matoba K; Yako H; Ohashi S; Sekiguchi K; Mitsuyoshi E; Sango K; Kawanami D; Utsunomiya K; Nishimura R
Biochem Biophys Res Commun; 2023 Mar; 649():32-38. PubMed ID: 36739697
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
